PURO Panitumumab in Combination With Gemcitabine/Cisplatin in Advanced Urothelial Cancer

This study has been terminated.
(The study was terminated due to insufficient recruitment.)
Sponsor:
Collaborator:
Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH
Information provided by (Responsible Party):
WiSP Wissenschaftlicher Service Pharma GmbH
ClinicalTrials.gov Identifier:
NCT01374789
First received: March 30, 2011
Last updated: March 7, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: July 2014
  Estimated Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)